{"log_id": 6365999459204631452, "direction": 0, "words_result_num": 41, "words_result": [{"probability": {"variance": 0.035836, "average": 0.853287, "min": 0.370884}, "location": {"width": 932, "top": 395, "height": 57, "left": 363}, "words": "高、瓷酸脱氢酶升高、前列腺异性抗原加、尿量增彩减少,淋巴细计数减少,中"}, {"probability": {"variance": 0.012941, "average": 0.916711, "min": 0.563894}, "location": {"width": 929, "top": 436, "height": 57, "left": 363}, "words": "性粒细胞计数减少、白胞升高降低、凝血试验异常、低密度蛋白增高、血原时间"}, {"probability": {"variance": 0.042845, "average": 0.859393, "min": 0.350336}, "location": {"width": 450, "top": 475, "height": 45, "left": 360}, "words": "延长、管型尿,尿白胞阳性尿蛋白阳性"}, {"probability": {"variance": 0.032954, "average": 0.879022, "min": 0.523926}, "location": {"width": 118, "top": 518, "height": 31, "left": 408}, "words": "心直管风险"}, {"probability": {"variance": 0.022779, "average": 0.919928, "min": 0.350125}, "location": {"width": 877, "top": 557, "height": 57, "left": 406}, "words": "在随机对照及长扩展性研究中,心血管市外和死亡是 APTC anti-platelet Trinlis!s"}, {"probability": {"variance": 0.027356, "average": 0.880414, "min": 0.372207}, "location": {"width": 779, "top": 596, "height": 59, "left": 514}, "words": "预先确定的终点(包活心血管死亡、致性心肌校死非致死性卒中)之"}, {"probability": {"variance": 0.017394, "average": 0.927098, "min": 0.51941}, "location": {"width": 886, "top": 637, "height": 57, "left": 402}, "words": "在机对照的日期试验中,每100患考一年APTC事件的发生率分别是:安慰剂组"}, {"probability": {"variance": 0.005879, "average": 0.936154, "min": 0.721089}, "location": {"width": 155, "top": 683, "height": 25, "left": 383}, "words": "95%C10.00-6."}, {"probability": {"variance": 0.024756, "average": 0.860393, "min": 0.448783}, "location": {"width": 678, "top": 683, "height": 52, "left": 607}, "words": "非右司40mg组0(95%C0.0C~L8).非布他mg组1.0S"}, {"probability": {"variance": 0.021163, "average": 0.861206, "min": 0.538091}, "location": {"width": 568, "top": 719, "height": 45, "left": 381}, "words": "5%C10.442.240、别醇组0.60(95%C10【6-.53〕"}, {"probability": {"variance": 0.032298, "average": 0.882469, "min": 0.38591}, "location": {"width": 886, "top": 758, "height": 59, "left": 399}, "words": "在长扩展性研究中,APTC事件的发生率分别是:非布问他0mg07(95%Cl"}, {"probability": {"variance": 0.020632, "average": 0.904209, "min": 0.385961}, "location": {"width": 500, "top": 801, "height": 34, "left": 354}, "words": "0571.56,和别组0.58(95%C10.02-3.24"}, {"probability": {"variance": 0.027393, "average": 0.898279, "min": 0.428084}, "location": {"width": 881, "top": 840, "height": 54, "left": 397}, "words": "总之把比于别嘌醇组非布司他治疗组具有较高的APTC事件发生率,但与非布司"}, {"probability": {"variance": 0.027342, "average": 0.892726, "min": 0.356404}, "location": {"width": 724, "top": 879, "height": 50, "left": 351}, "words": "的因果关系还确定,服药时应监测心肌梗死和卒中的症状和体征"}, {"probability": {"variance": 0.03428, "average": 0.913445, "min": 0.499617}, "location": {"width": 175, "top": 918, "height": 36, "left": 429}, "words": "产品上市控验"}, {"probability": {"variance": 0.029782, "average": 0.925117, "min": 0.351078}, "location": {"width": 890, "top": 959, "height": 59, "left": 392}, "words": "对非布司他上市使用中的不良反应进行了别,由于这些不良反应是从知数量的"}, {"probability": {"variance": 0.031832, "average": 0.891442, "min": 0.40849}, "location": {"width": 829, "top": 998, "height": 59, "left": 349}, "words": "者中自发投告的一因此不可能准评估其发生或判定其与药物的因果关系"}, {"probability": {"variance": 0.024063, "average": 0.907611, "min": 0.402149}, "location": {"width": 877, "top": 1044, "height": 57, "left": 392}, "words": "开胆异常肝功能(有些是致命的)、黄疸,肝功能检查结果严重异常、肝脏疾病"}, {"probability": {"variance": 0.030573, "average": 0.881745, "min": 0.536039}, "location": {"width": 239, "top": 1085, "height": 36, "left": 372}, "words": "疫系统:过"}, {"probability": {"variance": 0.040454, "average": 0.839857, "min": 0.397555}, "location": {"width": 217, "top": 1128, "height": 41, "left": 559}, "words": "织:横纹肌溶解症"}, {"probability": {"variance": 0.043547, "average": 0.831181, "min": 0.395533}, "location": {"width": 312, "top": 1171, "height": 41, "left": 507}, "words": "包括称击性候向的神病行"}, {"probability": {"variance": 0.001983, "average": 0.977026, "min": 0.832847}, "location": {"width": 317, "top": 1210, "height": 34, "left": 390}, "words": "泌尿系统:肾小管间质性肾炎"}, {"probability": {"variance": 0.01541, "average": 0.936984, "min": 0.541496}, "location": {"width": 358, "top": 1249, "height": 43, "left": 388}, "words": "皮肤和皮下组织全身性皮,St"}, {"probability": {"variance": 0.03172, "average": 0.907385, "min": 0.39058}, "location": {"width": 235, "top": 1261, "height": 34, "left": 884}, "words": "综合征,皮过敏反应"}, {"probability": {"variance": 0.001592, "average": 0.97265, "min": 0.9036}, "location": {"width": 82, "top": 1288, "height": 29, "left": 349}, "words": "【禁忌】"}, {"probability": {"variance": 0.04472, "average": 0.858257, "min": 0.36321}, "location": {"width": 523, "top": 1329, "height": 47, "left": 386}, "words": "本品禁用于正在接受唑呤、嘌治疗的思者"}, {"probability": {"variance": 0.000102, "average": 0.994514, "min": 0.974356}, "location": {"width": 130, "top": 1370, "height": 34, "left": 347}, "words": "【注意项】"}, {"probability": {"variance": 4.6e-05, "average": 0.985773, "min": 0.97927}, "location": {"width": 100, "top": 1414, "height": 29, "left": 386}, "words": "风发作"}, {"probability": {"variance": 0.026813, "average": 0.891615, "min": 0.421847}, "location": {"width": 881, "top": 1450, "height": 61, "left": 386}, "words": "在服用非布可他的切期,经常出现布风发作频增加,这是因为尿酸浓度降,导"}, {"probability": {"variance": 0.02391, "average": 0.917708, "min": 0.393582}, "location": {"width": 934, "top": 1491, "height": 61, "left": 333}, "words": "致组织中沉积的尿盐动员,为预防治疗初期的痛风发作。建议同时服用非体类抗炎药"}, {"probability": {"variance": 0.0337, "average": 0.792435, "min": 0.573362}, "location": {"width": 118, "top": 1535, "height": 36, "left": 338}, "words": "或秋水们碱"}, {"probability": {"variance": 0.039409, "average": 0.844462, "min": 0.424508}, "location": {"width": 884, "top": 1576, "height": 59, "left": 381}, "words": "在非布司治疗期问。如果消风发作,无中止非布仙治疗,应根据忠者的体情"}, {"probability": {"variance": 0.000214, "average": 0.989282, "min": 0.958354}, "location": {"width": 267, "top": 1615, "height": 41, "left": 331}, "words": "况,对痛风进行相应治疗"}, {"probability": {"variance": 0.060205, "average": 0.866563, "min": 0.376181}, "location": {"width": 121, "top": 1663, "height": 27, "left": 383}, "words": "心管事件"}, {"probability": {"variance": 0.020194, "average": 0.93794, "min": 0.405828}, "location": {"width": 884, "top": 1699, "height": 57, "left": 379}, "words": "在机对照研究中,相比使用别醇,使用非布司他治疗的患者发生心血管机栓事件"}, {"probability": {"variance": 0.008536, "average": 0.938226, "min": 0.541676}, "location": {"width": 927, "top": 1736, "height": 63, "left": 335}, "words": "(包括心虚管死亡,非致死性心肌死、非致死性脑卒中)的概率较高,其中布司他为"}, {"probability": {"variance": 0.033484, "average": 0.859276, "min": 0.369287}, "location": {"width": 929, "top": 1779, "height": 66, "left": 331}, "words": "074/00圆患者一年(95%C上:0.361.37),别嘌醇为0.0100例者一年5%C:"}, {"probability": {"variance": 0.03429, "average": 0.869611, "min": 0.416417}, "location": {"width": 847, "top": 1825, "height": 57, "left": 408}, "words": "53).尚未定非布司化与心血管血栓事竹的果关系,用药时注意监出心肌梗死"}, {"probability": {"variance": 0.034305, "average": 0.84211, "min": 0.460222}, "location": {"width": 244, "top": 1866, "height": 36, "left": 326}, "words": "利脑卒中的症状及体征"}, {"probability": {"variance": 0.034512, "average": 0.903328, "min": 0.531859}, "location": {"width": 125, "top": 1909, "height": 29, "left": 372}, "words": "肝脏的影响"}, {"probability": {"variance": 0.020293, "average": 0.901788, "min": 0.442001}, "location": {"width": 884, "top": 1946, "height": 61, "left": 372}, "words": "已有患者服用非布司他后出现激死性和非致死性开业衰竭的上市后报告,尽管这些报"}], "language": 3}